Non-‘classical’ MEKs: A review of MEK3-7 inhibitors
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference89 articles.
1. MAPK signal pathways in the regulation of cell proliferation in mammalian cells;Zhang;Cell Res,2002
2. Differential regulation and properties of MAPKs;Raman;Oncogene,2007
3. Mammalian MAP kinase signalling cascades;Chang;Nature,2001
4. MEK and the inhibitors: from bench to bedside;Akinleye;J Hematol Oncol,2013
5. Current development status of MEK inhibitors;Cheng;Molecules,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failure;Signal Transduction and Targeted Therapy;2024-07-03
2. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer;International Journal of Molecular Sciences;2024-02-03
3. Iterative machine learning-based chemical similarity search to identify novel chemical inhibitors;Journal of Cheminformatics;2023-09-23
4. MKK4 Inhibitors—Recent Development Status and Therapeutic Potential;International Journal of Molecular Sciences;2023-04-19
5. Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors;ACS Medicinal Chemistry Letters;2023-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3